Dr. Xiang-Qun Xie's lab at the University of Pittsburgh focuses on understanding the structure and function of cannabinoid receptors, particularly the CB2 receptor. They aim to develop new drugs that can modulate this receptor to treat chronic pain, autoimmune diseases, and other conditions, without the negative side effects associated with existing treatments. The lab combines advanced imaging techniques with computational methods to design and test new compounds that target these receptors.

Dr. Michael Emanuele's lab at the University of North Carolina Chapel Hill focuses on understanding how proteins regulate the cell cycle, particularly through a process called ubiquitination, which involves tagging proteins for degradation. His research examines the specific enzymes and proteins involved in this tagging process and their effects on cell growth and division. This work is crucial for uncovering how misregulation of these processes can lead to diseases like cancer.

Dr. David A. Nathanson's lab at UCLA focuses on understanding and exploiting novel mechanisms of cell death in glioblastoma, a highly aggressive brain tumor. The lab is particularly interested in a newly identified type of cell death called palmoptosis, which could offer a new approach to treating glioblastoma by overcoming the cancer's resistance to traditional therapies. Through investigating the molecular and metabolic characteristics of glioblastoma, the lab aims to identify potential therapeutic strategies to improve patient outcomes.

Dr. Louis Hodgson's lab at Albert Einstein College of Medicine focuses on developing and applying advanced imaging techniques to study how cells move and interact with their environment. They use innovative biosensors to observe key signaling pathways within living cells, particularly in relation to how cells migrate and invade in both normal and diseased states. By analyzing these complex cellular processes, their research aims to provide insights into important biological functions and disease mechanisms.

Dr. Daniel Wacker's research lab explores cellular transporters in the brain that regulate the pH balance, crucial for maintaining proper neuronal function. The lab focuses on understanding the structure and function of specific bicarbonate transporters linked to neurological disorders, aiming to develop tools for drug discovery that could lead to new treatments. By combining various scientific techniques, the lab seeks to uncover the molecular mechanisms behind these transporters and their potential therapeutic applications.

Dr. Lina Cui's lab at the University of Florida focuses on developing innovative therapies for age-related diseases, particularly Alzheimer's disease. By using a unique CAR-T cell immunotherapy approach, the lab aims to detect and eliminate senescent cells, which play a significant role in aging and associated disorders. The research could lead to groundbreaking treatments that improve health in the elderly population.

Boyuan Wang's research lab at UT Southwestern Medical Center explores how bacteria communicate and respond to stress through a molecule called (p)ppGpp. This molecule helps bacteria survive antibiotics by halting their growth. The lab focuses on understanding the role of enzymes that degrade (p)ppGpp and how metal stress from the human body affects these enzymes. The ultimate goal is to discover new treatment methods to combat persistent bacterial infections.

Dr. Xiaoli Sun's lab focuses on understanding the complex relationship between metabolic dysfunction and liver diseases, specifically metabolic dysfunction-associated steatohepatitis (MASH) and its progression to liver cancer. The research investigates how oxidized phospholipids (OxPLs) contribute to oxidative stress and impact liver health. By exploring the mechanisms of OxPLs and their role in liver injury, the lab aims to uncover new potential therapeutic strategies for these serious health conditions.

Dr. Prasad V Katakam's lab focuses on understanding how brain microvessels (BMVs) contribute to impaired cognitive function in Alzheimer's disease (AD), particularly how they are affected by peroxynitrite and sex differences. Using advanced techniques, the lab studies mitochondrial function and energy production in BMVs from different mouse models to uncover potential therapeutic targets to improve neurological health.

Dr. Scott Earley's lab at the University of Rochester focuses on understanding how the brain regulates blood flow through a network of specialized sensors known as TRP channels. These channels play a critical role in maintaining healthy microcirculation by responding to changes in the brain’s environment. The lab uses advanced techniques, such as imaging and genetics, to explore how these sensors work, especially during conditions like aging and related cerebrovascular diseases.

Dr. Qingguo Xu's lab is focused on developing innovative treatments for eye injuries caused by chemical exposure, specifically nitrogen mustard. The lab is working on a special eyedrop formulation that includes fenofibrate, a drug known for its anti-inflammatory properties, aiming to facilitate healing of corneal injuries. Their research includes testing the effectiveness of these eyedrops in animal models, as well as ensuring they are safe for use in humans.

Dr. James K. Chen's lab at Stanford University is focused on combining chemistry with developmental biology to understand how tissues form and how this relates to cancer. The lab develops innovative chemical tools, such as optogenetic systems and small-molecule inhibitors, to explore mechanisms behind cell differentiation and oncogenesis. By creating new experimental platforms, they aim to study important signaling pathways in development and cancer, ultimately seeking to contribute to new therapies for human diseases.

Dr. Wei Cheng's lab at the University of Michigan studies how B cells, a type of immune cell, recognize and respond to viruses and viral-like particles. By using advanced techniques to create model antigens, the lab explores the intricate mechanisms through which B cells are activated, leading to stronger immune responses. This research not only enhances our understanding of the immune system but also aids in the development of better vaccines against viral infections.

Dr. Lih-Shen Chin's lab at Emory University focuses on understanding Lewy body dementia (LBD), which includes conditions like Parkinson's disease dementia and dementia with Lewy bodies. The research aims to uncover the molecular mechanisms that contribute to LBD's development and how it differs from Alzheimer's disease. By analyzing proteins and sugars in the brain, the lab hopes to identify new diagnostic markers and treatments for this challenging form of dementia.

Dr. Gregory R. J. Thatcher's lab at the University of Arizona focuses on understanding how certain genetic factors and metabolic diseases, like type 2 diabetes and Alzheimer's disease, are interconnected. They aim to develop new drugs that can treat Alzheimer's by enhancing cholesterol metabolism without causing weight gain or other side effects. The lab uses a variety of animal models to test these potential treatments and investigate their effects on brain health.

Dr. Zaijie Jim Wang's research lab focuses on understanding the molecular mechanisms of chronic pain associated with sickle cell disease (SCD) to develop effective treatments. The lab uses advanced techniques like studying epigenetics and gut microbiota to uncover the biological processes behind this pain. Ultimately, the goal is to improve therapies that help the thousands of patients suffering from chronic pain linked to SCD.

Dr. Venetia Zachariou's lab at Boston University Medical Campus focuses on understanding chronic pain mechanisms, specifically looking at a protein called RGS4 that influences nerve signals. By studying how RGS4 functions in different types of nerve cells, the lab aims to identify new targets for pain management, potentially leading to safer and more effective treatments for people suffering from neuropathic pain.

Dr. Ning Zheng's lab focuses on understanding how heart rhythms are regulated at the molecular level. The team uses advanced imaging techniques to study proteins called sodium and calcium channels, which are crucial for heart cell function. By investigating their structure and function, especially in the context of mutations that cause arrhythmias, they aim to improve antiarrhythmic drug design for safer and more effective treatments.

Dr. Karlene Cimprich's lab focuses on understanding how cells respond to DNA damage, particularly when DNA replication is stressed due to environmental factors. Their research investigates a protein called HLTF, which plays a crucial role in repairing stalled DNA replication and preventing mutations that could lead to cancer. The lab combines advanced techniques in molecular biology and biochemistry to uncover the mechanisms that protect the genome and cellular health under stress, ultimately contributing to insights into cancer therapy.

Dr. David S. Lawrence's lab at the University of North Carolina Chapel Hill focuses on developing innovative drug delivery systems to improve treatments for thromboembolism, particularly in cancer patients. The lab's groundbreaking research utilizes a bioengineering approach that combines thrombolytic enzymes with vitamin B12 to create a targeted, effective delivery platform, using the body's circulatory system as a natural reservoir. This technology aims to enhance the safety and efficacy of thrombolytic therapies, especially in high-risk populations like cancer patients and pregnant women.